| Literature DB >> 28088223 |
Víðir Sigrúnarson1,2, Rolf W Gråwe1,3, Stian Lydersen4, Gunnar Morken5,6,7.
Abstract
BACKGROUND: The aim of study was to investigate predictors of long term use of psychiatric services of patients with recent-onset schizophrenia.Entities:
Keywords: Hospitalizations; Mental health service use; Schizophrenia
Mesh:
Year: 2017 PMID: 28088223 PMCID: PMC5237502 DOI: 10.1186/s12888-016-1186-x
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Possible predictors of long term use of services at baseline and observations during 2 years of treatment
| Baseline | Two years | |
|---|---|---|
| Demographics | ||
| Age | X | |
| Gender | X | |
| Urban / Rural | X | |
| ASSESSMENTS | ||
| Diagnosis | X | |
| Global Assessment of functioning (GAF) | X | X |
| Brief Psychiatric Rating Scale (BPRS) | X | X |
| Psychotic relapse: | X | |
| Persistent psychotic symptoms: | X | |
| Attempted suicide: | X | |
| Use of services | ||
| Hospitalized | Year preceding study entry | X |
| Days hospitalized | Year preceding study entry | X |
| No. of hospitalizations - | X | |
| Involuntary admitted | X | |
| Days involuntary admitted | X | |
| Outpatient coercion | X | |
| Days outpatient coercion | X | |
| Treatment | ||
| Integrated treatment | X | |
| Good adherence with oral or depot antipsychotics | X | |
| Good adherence with psychosocial treatment | X | |
Use of inpatient days through 12 years divided on Integrated treatment and Treatment as usual the two preceding years
| Integrated Treatment | Treatment as usual | ||
|---|---|---|---|
| Non-frequent users | No admittances | 13 | 4 |
| 0 to 100 days | 3 | 1 | |
| Frequent users | 100 to 500 days | 6 | 8 |
| More than 500 days | 6 | 4 |
Bivariate analysis of baseline predictors for long time use of services
| Total | Frequent users ( | Non-frequent users ( |
| ||||
|---|---|---|---|---|---|---|---|
| Demographics | |||||||
| Age. Mean (SD) | 24.5 (4.5) | 23.9 (4.0) | 25.1 (4.9) | .36 a) | |||
| Female, No. (%) | 18 (40) | 13 (54) | 5 (24) | .045*c) | |||
| Urban No. (%) | 27 (60) | 15 (63) | 12 (57) | .76 c) | |||
| Diagnosis DSM-IV | |||||||
| Schizophrenia | 37 (82) | 20 (83) | 17 (81) | - | |||
| - Schizo-affective | 6 (13) | 3 (13) | 3 (14) | - | |||
| - Schizophreni-form | 2 (5) | 1 (4) | 1 (5) | - | |||
| GAF baseline. | 49.7 (10.7) | 45.8 (9.1) | 54.1 (10.9) | .007*a) | |||
| BPRS baseline, 24 items. Mean (SD) | 39.7 (7.6) | 42.1 (7.5) | 36.9 (6.9) | .020*a) | |||
| - Neg. sympt. Mean (SD) | 9.4 (3.4) | 9.7 (3.5) | 9.1 (3.2) | .55 a) | |||
| - Pos. sympt. Median, (mean) | 9 (9.6) | 10.5 (10.7) | 7 (8.3) | .021*b) | |||
| Min | Max | Min | Max | Min | Max | ||
| 6 | 18 | 6 | 18 | 6 | 17 | ||
| Use of services | |||||||
| Hospitalized before study entry No (%) | 39 (87) | 20 (83) | 19 (90) | .53 c) | |||
| Days hospitalized year preceding study entry. Mean (SD) | 130.8 (103.2) | 119.7 (98.2) | 143.4 (109.7) | .45 a) | |||
BPRS Brief Psychiatric Rating Scale
GAF Global assessment of function
SD Standard deviation
a) T-test, b) Mann-Whitney test c) Exact unconditional z-pooled test
*Statistically significant
Bivariate analysis of predictors for long time services, 2 years after inclusion
| Total ( | Frequent users ( | Non-frequent users ( |
| ||||
|---|---|---|---|---|---|---|---|
| Assessments | |||||||
| GAF 24 months. Mean (SD) | 55.2 (17.3) | 49.1 (13.8) | 62.1 (18.5) | .010* a) | |||
| BPRS 24 items, 2 years. Mean (SD) | 36.4 (9.2) | 39.8 (7.5) | 32.5 (9.7) | .007* a) | |||
| -Neg. symptoms Mean (SD) | 7.7 (3.7) | 8.0 (3.7) | 7.4 (3.7) | .63 a) | |||
| -Pos. symptoms Median (mean) | 8 (9.8) | 9 (10.6) | 6 (8.8) | .009* b) | |||
| Min | Max | Min | Max | Min | Max | ||
| 6 | 29 | 6 | 18 | 6 | 29 | ||
| Psychotic relapse 2 years. No. (%) | 23 (51) | 17 (71) | 6 (29) | .008* c) | |||
| Persistent psychotic sxs 0–24 months. No. (%) | 11 (24) | 8 (33) | 3 (14) | .14 c) | |||
| Attempted suicide 2 years. No (%) | 5 (11) | 5 (21) | 0 (0) | .032* c) | |||
| Use of services | |||||||
| Hospitalized 0–24 months. No (%) | 20 (44) | 16 (67) | 4 (19) | .001* c) | |||
| No. of hospitalizations 0–24 months. Median (mean) | 0 (1.2) | 1 (2.1) | 0 (0.2) | .001* b) | |||
| Min | Max | Min | Max | Min | Max | ||
| 0 | 16 | 0 | 16 | 0 | 2 | ||
| Days inpatient 0–24 months. Median (mean) | 0 (55.8) | 25.5 (92.2) | 0 (14.2) | .001* b) | |||
| Min | Max | Min | Max | Min | Max | ||
| 0 | 295 | 0 | 295 | 0 | 235 | ||
| Involuntary admitted 0–24 months. No. (%) | 18 (40) | 13 (54) | 5 (24) | .045* c) | |||
| Days involuntary admitted 0–24 months. Median (mean) | 0 (41.9) | 10.5 (63.5) | 0 (17.2) | .025* b) | |||
| Min | Max | Min | Max | Min | Max | ||
| 0 | 294 | 0 | 294 | 0 | 236 | ||
| Outpatient coercion 0–24 months. No. (%) | 6 (13) | 6 (25) | 0 (0) | .015* c) | |||
| Days outpatient coercion 0–24 months. Median (mean) | 0 (47.0) | 0 (88.1) | 0 (0.00) | .015* b) | |||
| Min | Max | Min | Max | Min | Max | ||
| 0 | 560 | 0 | 560 | 0 | 0 | ||
| Treatment | |||||||
| Integrated treatment No. (%) | 28 (62) | 12 (50) | 16 (76) | .078 c) | |||
| Good adherence with oral or depot antipsychotics. No. (%) | 32 (71) | 14 (58) | 18 (86) | .049* c) | |||
| Good adherence with psychosocial treatment No. (%) | 41 (91) | 21 (87.5) | 20 (95) | .47 c) | |||
GAF Global assessment of function
BPRS Brief Psychiatric Rating Scale
a) T-test, b) Mann-Whitney test c) Exact unconditional z-pooled test
*Statistically significant
Logistic regression analysis of baseline and 2 year predictors for long time use of services
| OR unadjusted | OR adjusted for age, gender and treatment group | |||
|---|---|---|---|---|
| Estimate (CI) |
| Estimate (CI) |
| |
| Predictors baseline | ||||
| Age (years) | 0.94 (0.82 to 1.07) | 0.36 | 0.962 (0.833 to 1.11) | 0.599 |
| Male gender | 0.26 (0.073 to 0.96) | 0.043a | 0.25 (0.064 to 0.970) | 0.045a |
| BPRS baseline | 1.11 (1.01 to 1.21) | 0.028a | 1.10 (0.997–1.121) | 0.057 |
| Days as inpatient 1 year preceding baseline | 0.998 (0.992 to 1.004) | 0.44 | 0.998 (0.992 to 1.004) | 0.496 |
| Negative symptoms | 0.889 (0.727–1.088) | 0.253 | 0.855 (0.677–1.080) | 0.19 |
| GAF baseline | 0.913 (0.854–0.982) | 0.013a | 0.92 (0.857–0.989) | 0.024a |
| Predictors 2 years | ||||
| BPRS 2 years | 1.10 (1.02 to 1.19) | 0.013a | 1.1 (1.006 to 1.20) | 0.036a |
| Days as inpatient 2 years after baseline | 1.013 (1.002–1.024) | 0.023a | 1.010 (0.999 to 1.022) | 0,082 |
| Integrated treatment or Treatment as usual | 0.31 (0.087 to 1.13) | 0.076 | 0.29 (0.073 to 1.14) | 0.077 |
| Admitted to hospital the first 2 years after baseline | 8.5 (2.137–33.814) | 0.002a | 10.411 (1.956–55.399) | 0.006a |
| Negative symptoms | 0.935 (0.773–1.129) | 0.484 | 0.845 (0.673–1.060) | 0.146 |
| GAF | 0.950 (0.912–0.991) | 0.017a | 0.949 (0.907–0.993) | 0.023a |
| Compliance medication | 4.286 (0.988–18.586) | 0.052 | 0.097 (0.015–0.607) | 0.013a |
| Absence of psychotic relapse | 0.165 (0.045–0.600) | 0.006a | 0.135 (0.029–0.632) | 0.010a |
BPRS Brief Psychiatric Rating Scale
GAF Global Assessment of Function
asignificant results
Prediction of being a frequent user of inpatient days during 12 years. Divided in in a high risk group defined as being admitted or having a suicide attempt or outpatient coercion the preceding 2 years of treatment
| User group | ||
|---|---|---|
| Frequent user | Non frequent user | |
| High risk group | 18 | 4 |
| Low risk group | 6 | 17 |
Sensitivity 75%, Specificity 81%, Positive predictive value 82%, Negative predictive value 74%